HIPEC + EPIC versus HIPEC-alone: Differences in major complications following cytoreduction surgery for peritoneal malignancy

Journal of Surgical Oncology

Volumn 107, Issue 6, 2013, Pages 591-596

  McConnell, Yarrow J ^a   MacK, Lloyd A ^a   Francis, Wesley P ^a   Ho, Thomas ^a   Temple, Walley J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

carcinomatosis; HIPEC; peritoneal

Indexed keywords

FLUOROURACIL; MITOMYCIN;

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURGERY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PERITONEUM METASTASIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROPERITONEAL ABSCESS; VEIN THROMBOSIS;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; LOGISTIC MODELS; MALE; MIDDLE AGED; MITOMYCIN; MULTIVARIATE ANALYSIS; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PERITONEUM; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84876391694     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23276     Document Type: Article

References (29)

1. Koppe MJ, Boerman OC, Oyen WJG, et al.: Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg 2006; 243: 212-222.
2. Katz MH, Barone RM,: The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am 2003; 12: 673-688.
3. Moran BJ, Cecil TD,: The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003; 12: 585-603.
4. Smeenk RM, van Velthuysen MLF, Verwaal VJ, et al.: Appendiceal neoplasms and pseudomyxoma peritonei: A population based study. Eur J Surg Oncol 2008; 34: 196-201.
5. Verwaal VJ, Bruin S, Boot H, et al.: 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426-2432.
6. Elias D, Lefevre JH, Chevalier J, et al.: Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27: 681-685.
7. Franko J, Ibrahim Z, Gusani NJ, et al.: Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 2010; 116: 3756-3762.
8. Chua TC, Morris DL, Saxena A, et al.: Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: A multicenter study. Ann Surg Oncol 2011; 18: 1560-1567.
9. Piché N, Leblond FA, Sidéris L, et al.: Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: A study of the effect of heat on intraperitoneal oxaliplatin using a murine model. Ann Surg 2011; 254: 138-144.
10. Glehen O, Gilly FN, Boutitie F, et al.: Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: A multi-institutional study of 1,290 patients. Cancer 2010; 116: 5608-5618.
11. Elias D, Benizri E, Di Pietrantonio D, et al.: Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 2007; 14: 509-514.
12. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004; 22: 3284-3292.
13. Dindo D, Demartines N, Clavien P-A,: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
14. Ronnett BM, Zahn CM, Kurman RJ, et al.: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei. " Am J Surg Pathol 1995; 19: 1390-1408.
15. Carr N, Sobin LH,: Tumors of the appendix. In:, Bosman F, Carneiro F, Hruban RH, et al., editors. World Health Organization classification of tumours: Pathology and genetics of tumours of the digestive system. Lyon, France: IARC Press; 2010. pp. 122-125.
16. Harmon RL, Sugarbaker PH,: Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Sem Surg Oncol 2005; 2: 3.
17. Chua TC, Saxena A, Schellekens JF, et al.: Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: Towards a new perspective of this treatment. Ann Surg 2010; 251: 101-106.
18. Gusani NJ, Cho SW, Colovos C, et al.: Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol 2008; 15: 754-763.
19. Saxena A, Yan TD, Morris DL,: A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. World J Surg 2010; 34: 70-78.
20. Stephens AD, Alderman R, Chang D, et al.: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6: 790-796.
21. Klaver YLB, Hendriks T, Lomme RMLM, et al.: Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: An experimental study. Ann Surg Oncol 2011; 19 (Suppl 3): S475-482.
22. van der Kolk BM, de Man BM, Wobbes T, et al.: Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine? Br J Cancer 1999; 79: 545-550.
23. Smeenk RM, Verwaal VJ, Zoetmulder FAN,: Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures. Eur J Surg Oncol 2006; 32: 186-190.
24. Moradi BN, Esquivel J,: Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2009; 100: 293-296.
25. Smeenk RM, Verwaal VJ, Zoetmulder FAN,: Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 2007; 94: 1408-1414.
26. Elias D, Gilly F, Boutitie F, et al.: Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28: 63-68.
27. Saxena A, Yan TD, Chua TC, et al.: Risk factors for massive blood transfusion in cytoreductive surgery: A multivariate analysis of 243 procedures. Ann Surg Oncol 2009; 16: 2195-2203.
28. Elias D, Honoré C, Ciuchendéa R, et al.: Peritoneal pseudomyxoma: Results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008; 95: 1164-1171.
29. Saxena A, Yan TD, Chua TC, et al.: Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 2010; 17: 1291-1301.